Skip to main content
Retour
Watch Compare

CytoDyn Inc.

Qualité des données : 83%
CYDY
OTC Manufacturing Chemicals
0,29 €
▲ 0,02 € (7,04%)
Cap. Boursière: 392,21 M
Prix
0,29 €
Cap. Boursière
392,21 M
Fourchette du Jour
0,28 € — 0,29 €
Fourchette 52 Semaines
0,20 € — 0,45 €
Volume
386 514
Ouverture 0,29 €
Moyenne 50J / 200J
0,25 €
13,78% above
Moyenne 50J / 200J
0,28 €
3,96% above

Quick Summary

Points Clés

Negative free cash flow of -17,98 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio0,37
Interest CoverageN/A

Valorisation

PE (TTM)
-10,11
En dessous de la moyenne du secteur (-1,98)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (44 pairs)
Métrique Action Médiane du Secteur
P/E -10,1 -2,0
P/B — 5,1
ROE % — -51,0
Net Margin % — -150,2
Rev Growth 5Y % — 9,3
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -38,79 M
ROE N/A ROA -282,83%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -17,98 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,37
Interest Coverage N/A Asset Turnover N/A
Working Capital -31,99 M Tangible Book Value -104,29 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -10,11 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -4,58%
Market Cap 392,21 M Enterprise Value 417,09 M
Per Share
EPS (Diluted TTM) -0,04 Revenue / Share N/A
FCF / Share -0,01 OCF / Share -0,01
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 46,35%
SBC-Adj. FCF -19,13 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — 0,0 266 000,0 —
Net Income 3,75 M -49,84 M -79,82 M -210,82 M -154,67 M
EPS (Diluted) 0,00 -0,05 -0,10 -0,31 —
Gross Profit — — 213 000,0 213 000,0 —
Operating Income 9,66 M -18,06 M -40,58 M -145,40 M -104,60 M
EBITDA — — — — —
R&D Expenses — 7,24 M 2,63 M 27,04 M 58,43 M
SG&A Expenses — — — — —
D&A 18 000,0 29 000,0 175 000,0 781 000,0 —
Interest Expense — 31,78 M 39,25 M 65,42 M —
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 18,05 M 11,14 M 11,29 M 29,19 M 132,08 M
Total Liabilities 114,09 M 127,89 M 120,79 M 123,58 M 153,10 M
Shareholders' Equity -96,04 M -116,76 M -109,50 M -94,40 M -21,02 M
Total Debt 45,35 M 45,02 M 45,73 M 42,22 M —
Cash & Equivalents 11,90 M 3,11 M 2,54 M 4,23 M 33,94 M
Current Assets 17,88 M 10,82 M 10,81 M 10,52 M 129,58 M
Current Liabilities 70,52 M 84,18 M 119,80 M 123,16 M 152,55 M